Company: ERAS
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103868
Chunk: 51

Company: Erasca, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 51
---
 |                      |          — |    |
| Total                                                      |     |                   | 33,910,721 |    |     | $                 | 3.93 |    |     |                      | 14,835,810 |    |

| (1) | Includes 25,925,048 shares of common stock that were subject to outstanding option awards as of December 31, 2024 under the 2021 Plan and 7,985,673 shares of common stock that were subject to outstanding option awards as of December 31, 2024 under the 2018 Plan. |

33

| (2) | Represents the weighted-average exercise price of outstanding options. |

| (3) | Includes 13,265,858 shares of common stock available for issuance under the 2021 Plan and 1,569,952 shares of common stock available for issuance under the 2021 ESPP (all of which were eligible for purchase pursuant to the offering period in effect on December 31, 2024). This amount does not include any additional shares that may become available for future issuance under the 2021 Plan pursuant to the automatic increase to the share reserve on January 1 of each of our calendar years through 2031 by the number of shares equal to the lesser of (i) 5% of the total outstanding shares of our common stock as of the immediately preceding December 31 and (ii) such smaller number of shares as is determined by our Board. Additionally, this amount does not include any additional shares that may become available for future issuance under the 2021 ESPP pursuant to the automatic increase to the share reserve on January 1 of each of our calendar years through 2031 by the number of shares equal to the lesser of (i) 1% of the total outstanding shares of our common stock as of the immediately preceding December 31 and (ii) such smaller number of shares as determined by our Board. |

34

Security Ownership of Certain Beneficial Owners and Management The following table and accompanying footnotes set forth certain information with respect to the beneficial ownership of our common stock at April 15, 2025 for:

| • |     | each of our directors; |

| • |     | each of our NEOs; |

| • |     | all of our current directors and executive officers as a group; and |

| • |     | each person, or group of affiliated persons, who beneficially owned more than 5% of our outstanding common stock